Discovery

Analytical

Pre-Clinical

Patents

 

Pre-Clinical Accomplishments

Besides chemical accomplishments of chemical identification, dissolution, excipient formulations, etc., of our API, ABR has completed a pharmacokentic (PK) in animals in conjunction with an FDA approved good laboratory practice (GLP) pre-clinical facility.  The study showed favorable blood levels of our active pharmaceutical ingredient (API) over time in urine and plasma as well as excretion of our API. PK studies are required by the FDA in order to receive acceptance for FDA Investigational Drug (IND).

storefront_image